Description
An mGluR5 PAM; induces calcium mobilization in HEK293 cells expressing human mGluR5 (EC50 = 260 nM); selective for mGluR5 over mGluR1-4 and mGluR6-8 at 10 μM; reverses amphetamine-induced hyperlocomotion in rats (ED50 = 23 mg/kg), indicating antipsychotic-like activity; increases levels of c-fos and expression of BDNF, Arc/Arg3.1, syntaxin 1A, and PSD-95 in the hippocampus in the BACHD mouse model of Huntington’s disease at 3 mg/kg; improves object location memory in the novel object location test and associative memory in the cued fear conditioning test in the BACHD mouse model at 3 mg/kg
Formal name: [6,7-dihydro-2-(phenoxymethyl)oxazolo[5,4-c]pyridin-5(4H)-yl](4-fluorophenyl)-methanone
Synonyms: JNJ-46778212
Molecular weight: 352.4
CAS: 1363281-27-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Allosteric Modulators||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis||Research Area|Neuroscience|Neurodegenerative Disorders|Huntington’s Disease